Aytu bioscience announces acceleration of u.s. availability of covid-19 igg/igm rapid test

Aytu bioscience inc - announces acceleration of u.s. availability of covid-19 igg/igm rapid test based on updated fda policy.aytu bioscience inc - believe fda's updated policy may enable near-term availability of our recently-licensed point-of-care test.aytu bioscience inc - company will continue to provide updates about near-term availability of covid-19 test.
AYTU Ratings Summary
AYTU Quant Ranking